Evommune (EVMN) Non-Current Assets (2024 - 2026)

Evommune (EVMN) has 3 years of Non-Current Assets data on file, last reported at $106.6 million in Q1 2026.

• Non-Current Assets for Q1 2026 came in at $106.6 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $182.7 million (changed N/A YoY), and the FY2025 annual result was $71.5 million, up 3357.57% from the prior year.
• Non-Current Assets improved to $106.6 million in Q1 2026 per EVMN's latest filing, from $71.5 million in the prior quarter.
• Over five years, Non-Current Assets peaked at $106.6 million in Q1 2026 and troughed at $2.1 million in Q4 2024.
• A 3-year average of $45.7 million and a median of $37.0 million in 2025 frame the typical range for Non-Current Assets.
• On a YoY basis, Non-Current Assets climbed as much as 3357.57% in 2025 and fell as far as 3357.57% in 2025.
• A 3-year view of Non-Current Assets shows it stood at $2.1 million in 2024, then jumped by 3357.57% to $71.5 million in 2025, then surged by 49.16% to $106.6 million in 2026.
• Business Quant data shows EVMN's Non-Current Assets at $106.6 million in Q1 2026, $71.5 million in Q4 2025, and $2.6 million in Q3 2025.